|
CN105251008A
|
|
Application of Micro RNA-155 antagonist in preparation of drug for treating scleroderma
|
|
CN105251019A
|
|
Inhibition of invasion and transferring of prostatic cancer by utilization of targeting polar molecule Par3
|
|
CN105233345A
|
|
Natural protein/polycaprolactone nanofiber electrospun membrane, and preparation and application thereof
|
|
CN104991066A
|
|
Colorectal cancer prognosis diagnosis biological marker, kit and application of the biological marker
|
|
CN104931697A
|
|
Role of CD248+CD8+T cell subset in lesion process of aneurysm of human ascending aorta
|
|
CN104958306A
|
|
Application of compound Hu-17 alone or in combination with platinum drugs in preparing drugs for treating ovarian cancer
|
|
CN104758287A
|
|
Use of specific enzyme activity inhibitor RO-3306 of cell cyclin-dependent kinase 1
|
|
CN104587528A
|
|
Acellular matrix of human heart valve tissue and preparation and application of acellular matrix
|
|
CN104313145A
|
|
Application of miRNA-30e in preparation of diagnostic reagents as marker molecules
|
|
CN104278100A
|
|
Applications of miRNA-188 in preparation of diagnosis reagent as labelled molecule
|
|
CN104313142A
|
|
Application of miRNA-30a in preparation of diagnostic reagents as marker molecules
|
|
CN104138603A
|
|
Application of microRNA-7 for inhibiting prostate tumor growth and prostate tumor progress
|
|
CN104436195A
|
|
Use of miR-155 in preparation of acute lung injury prevention and treatment drugs
|
|
CN103239624A
|
|
Chinese medicine for treating oligospermia and asthenozoospermia owning to insufficiency of both spleen and kidney
|
